Tandem Diabetes Care Inc (TNDM) — Capital Reinvestment Ratio
Tandem Diabetes Care Inc (TNDM) has a Capital Reinvestment Ratio of 0.57x as of March 2026, meaning it reinvests 1% of its operating cash flow ($11.05 Million) in capital expenditures ($6.27 Million). Check TNDM goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tandem Diabetes Care Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Tandem Diabetes Care Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see TNDM operating cash flow.
Annual Capital Reinvestment Ratio for Tandem Diabetes Care Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Tandem Diabetes Care Inc from 2019 to 2024. See how much free cash does Tandem Diabetes Care Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | $24.23 Million | $19.23 Million | ▲ +17.5% |
| 2022 | 0.68x | $50.46 Million | $34.10 Million | ▲ +220.0% |
| 2021 | 0.21x | $111.36 Million | $23.51 Million | ▼ -83.9% |
| 2020 | 1.31x | $24.67 Million | $32.29 Million | ▲ +180.7% |
| 2019 | 0.47x | $41.91 Million | $19.54 Million | — |